Plasma Antioxidants Are Associated with Impaired Lung Function and COPD Exacerbations in Smokers

被引:74
作者
Nicks, Michael E. [1 ]
O'Brien, Maureen M. [2 ]
Bowler, Russell P. [1 ]
机构
[1] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA
[2] Univ Colorado, Dept Clin Sci, Denver, CO 80202 USA
关键词
antioxidants; glutathione; uric acid; plasma; COPD; exacerbation; OBSTRUCTIVE PULMONARY-DISEASE; 3 EUROPEAN COUNTRIES; MIDDLE-AGED MEN; OXIDATIVE STRESS; URIC-ACID; SYSTEMIC INFLAMMATION; VITAMIN-C; FOLLOW-UP; GLUTATHIONE; CANCER;
D O I
10.3109/15412555.2011.579202
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
100201 [内科学];
摘要
Low molecule weight antioxidants such as uric acid (UA), glutathione (GSH), and ascorbate (ASC) counter the effects of oxidants produced by cigarette smoke. Although dietary intake of foods rich in antioxidants has been associated with a reduced risk of smokers developing chronic obstructive pulmonary disease (COPD), the association between plasma antioxidants and COPD is less clear. In this cross-sectional study we investigated the relationship among plasma antioxidants and COPD phenotypes (severity of airflow obstruction on spirometry and history of exacerbations) in 136 smokers with normal lung function and 367 smokers with COPD. In the multivariate analysis, a lower plasma UA was associated with more severe COPD (P < 0.002) and a lower GSH was associated with a history of COPD exacerbations (P = 0.03); ASC was not associated with any COPD phenotypes. This suggests that antioxidant balance is impaired in smokers with obstruction on spirometry or a history of COPD exacerbations.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 49 条
[2]
URIC-ACID PROVIDES AN ANTIOXIDANT DEFENSE IN HUMANS AGAINST OXIDANT-CAUSED AND RADICAL-CAUSED AGING AND CANCER - A HYPOTHESIS [J].
AMES, BN ;
CATHCART, R ;
SCHWIERS, E ;
HOCHSTEIN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (11) :6858-6862
[3]
Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD [J].
Beeh, KM ;
Beier, J ;
Koppenhoefer, N ;
Buhl, R .
CHEST, 2004, 126 (04) :1116-1122
[4]
Bowler Russell P, 2004, COPD, V1, P255, DOI 10.1081/COPD-200027031
[5]
The levels of serum vitamin C, malonyldialdehyde and erythrocyte reduced glutathione in chronic obstructive pulmonary disease and in healthy smokers [J].
Çalikoglu, M ;
Ünlü, A ;
Tamer, L ;
Ercan, B ;
Bugdayci, R ;
Atik, U .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (10) :1028-1031
[6]
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS):: a randomised placebo-controlled trial [J].
Decramer, M ;
Rutten-van Mölken, M ;
Dekhuijzen, PNR ;
Troosters, T ;
van Herwaarden, C ;
Pellegrino, R ;
van Schayck, CPO ;
Olivieri, D ;
Del Donno, M ;
De Backer, W ;
Lankhorst, I ;
Ardia, A .
LANCET, 2005, 365 (9470) :1552-1560
[7]
Oxidative stress and airway inflammation in severe exacerbations of COPD [J].
Drost, EM ;
Skwarski, KM ;
Sauleda, J ;
Soler, N ;
Roca, J ;
Agusti, A ;
MacNee, W .
THORAX, 2005, 60 (04) :293-300
[8]
Global strategy for the diagnosis, management and prevention of COPD: 2003 [J].
Fabbri, LM ;
Hurd, SS .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (01) :1-2
[9]
Serum uric acid to creatinine ratio in patients with chronic obstructive pulmonary disease [J].
Garcia-Pachon, Eduardo ;
Padilla-Navas, Isabel ;
Shum, Conrado .
LUNG, 2007, 185 (01) :21-24
[10]
Altered antioxidant status in peripheral skeletal muscle of patients with COPD [J].
Gosker, HR ;
Bast, A ;
Haenen, GRMM ;
Fischer, MAJG ;
van der Vusse, GJ ;
Wouters, EFM ;
Schols, AMWJ .
RESPIRATORY MEDICINE, 2005, 99 (01) :118-125